Abstract
Inflammation of the preterm lungs is key to the pathogenesis of bronchopulmonary dysplasia (BPD), whether it arises as a consequence of intrauterine inflammation or postnatal respiratory management. This review explores steroidal and non-steroidal therapies for reducing neonatal pulmonary inflammation, aimed at treating or preventing BPD.
Author supplied keywords
Cite
CITATION STYLE
APA
Papagianis, P. C., Pillow, J. J., & Moss, T. J. (2019, April 1). Bronchopulmonary dysplasia: Pathophysiology and potential anti-inflammatory therapies. Paediatric Respiratory Reviews. W.B. Saunders Ltd. https://doi.org/10.1016/j.prrv.2018.07.007
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free